DrugPatentWatch Database Preview
Details for Patent: 6,946,149
Which drugs does patent 6,946,149 protect, and when does it expire?
Patent 6,946,149 protects SUPREP BOWEL PREP KIT and is included in one NDA.
This patent has twenty-seven patent family members in thirteen countries.
Summary for Patent: 6,946,149
| Title: | Salt solution for colon cleansing |
| Abstract: | The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function. |
| Inventor(s): | Cleveland; Mark vB. (Duxbury, MA) |
| Assignee: | Braintree Laboratories, Inc. (Braintree, MA) |
| Application Number: | 10/135,857 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,946,149 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; |
Drugs Protected by US Patent 6,946,149
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Braintree Labs | SUPREP BOWEL PREP KIT | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 022372-001 | Aug 5, 2010 | AA | RX | Yes | Yes | Start Trial | Start Trial | Y | GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,946,149
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 457172 | Start Trial | |||
| Austria | 528011 | Start Trial | |||
| Australia | 2003231160 | Start Trial | |||
| Canada | 2484303 | Start Trial | |||
| Cyprus | 1110011 | Start Trial | |||
| Cyprus | 1112522 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
